Screener
First Tracks Biotherapeutics Inc TRAX Cash Flow Statement
| Q1 '26 | ||
|---|---|---|
| -$50.48M-7.0% | ||
| $125K-14.4% | ||
| $11.5M+48.5% | ||
| -$32.56M+27.7% | ||
| $17K-51.4% | ||
| $34.98M+136% | ||
| $7.85M+37.4% | ||
| $10.27M+142% | ||
| -$32.58M+27.7% |
| Q1 '26 | ||
|---|---|---|
| -$50.48M-7.0% | ||
| $125K-14.4% | ||
| $11.5M+48.5% | ||
| -$32.56M+27.7% | ||
| $17K-51.4% | ||
| $34.98M+136% | ||
| $7.85M+37.4% | ||
| $10.27M+142% | ||
| -$32.58M+27.7% |